Harlan F. Weisman - 15 Aug 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role: President and CEO, Director
Signature: /s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 15 Aug 2023
Net transactions value: +$150,000
Form type: 4
Filing time: 15 Aug 2023, 08:00:17 UTC
Previous filing: 13 Mar 2023
Next filing: 22 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TFFP	Common Stock	Purchase	$150,000	+600,000	+280%	$0.2500	814,615	15 Aug 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.